HomeCompareCATI vs MRK

CATI vs MRK: Dividend Comparison 2026

CATI yields 666.67% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CATI wins by $608115.60M in total portfolio value
10 years
CATI
CATI
● Live price
666.67%
Share price
$0.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$608115.66M
Annual income
$469,561,018,816.25
Full CATI calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CATI vs MRK

📍 CATI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCATIMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CATI + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CATI pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CATI
Annual income on $10K today (after 15% tax)
$56,666.67/yr
After 10yr DRIP, annual income (after tax)
$399,126,865,993.81/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CATI beats the other by $399,126,857,665.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CATI + MRK for your $10,000?

CATI: 50%MRK: 50%
100% MRK50/50100% CATI
Portfolio after 10yr
$304057.86M
Annual income
$234,780,514,307.19/yr
Blended yield
77.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CATI
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CATI buys
0
MRK buys
0
No recent congressional trades found for CATI or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCATIMRK
Forward yield666.67%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$608115.66M$56.8K
Annual income after 10y$469,561,018,816.25$9,798.13
Total dividends collected$596792.85M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CATI vs MRK ($10,000, DRIP)

YearCATI PortfolioCATI Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$77,367$66,666.67$11,206$366.19+$66.2KCATI
2$564,818$482,035.31$12,650$502.35+$552.2KCATI
3$3,893,246$3,288,890.67$14,407$694.19+$3.88MCATI
4$25,352,760$21,186,987.16$16,585$967.82+$25.34MCATI
5$156,070,781$128,943,327.59$19,342$1,363.89+$156.05MCATI
6$908,837,800$741,842,064.29$22,913$1,947.19+$908.81MCATI
7$5,009,769,782$4,037,313,336.56$27,662$2,823.89+$5009.74MCATI
8$26,159,339,258$20,798,885,591.56$34,159$4,173.35+$26159.31MCATI
9$129,490,317,125$101,499,824,118.87$43,337$6,308.80+$129490.27MCATI
10$608,115,658,140$469,561,018,816.25$56,776$9,798.13+$608115.60MCATI

CATI vs MRK: Complete Analysis 2026

CATIStock

Clone Algo Technologies Inc., a technology company, develops algorithms and risk management systems based on artificial intelligence. Its products include Clone Algo, a social investment network app that enables users to clone trades from master accounts to users own account with connected brokers, banks, and hedge funds using algorithms, and advanced cloning and non-predictive timing technology; HomeAway, a hotel booking and management system for booking discounted hotel room rates; and AlgoTrust, a mobile banking system for do it yourself banking. The company was formerly known as Travelsafe, Inc. and changed its name to Clone Algo Technologies Inc. in September 2014. Clone Algo Technologies Inc. was founded in 2013 and is based in Chapel Hill, North Carolina.

Full CATI Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CATI vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CATI vs SCHDCATI vs JEPICATI vs OCATI vs KOCATI vs MAINCATI vs JNJCATI vs ABBVCATI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.